334 related articles for article (PubMed ID: 10502231)
1. A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.
Tcheng JE
Am Heart J; 1999 Oct; 138(4 Pt 2):261-2. PubMed ID: 10502231
[No Abstract] [Full Text] [Related]
2. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
Batchelor WB; Tolleson TR; Huang Y; Larsen RL; Mantell RM; Dillard P; Davidian M; Zhang D; Cantor WJ; Sketch MH; Ohman EM; Zidar JP; Gretler D; DiBattiste PM; Tcheng JE; Califf RM; Harrington RA
Circulation; 2002 Sep; 106(12):1470-6. PubMed ID: 12234950
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists].
Araujo R; Agustà A
Med Clin (Barc); 2000 Oct; 115(11):435-7. PubMed ID: 11093849
[No Abstract] [Full Text] [Related]
4. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Bhatt DL; Topol EJ
JAMA; 2000 Sep; 284(12):1549-58. PubMed ID: 11000650
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Roe MT; Sapp SK; Lincoff AM
Cleve Clin J Med; 2000 Feb; 67(2):131-40. PubMed ID: 10680279
[TBL] [Abstract][Full Text] [Related]
6. GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.
Chew DP; Moliterno DJ
Cleve Clin J Med; 2001 Dec; 68(12):1017-23. PubMed ID: 11765119
[TBL] [Abstract][Full Text] [Related]
7. Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
Lincoff AM; Califf RM; Topol EJ
J Am Coll Cardiol; 2000 Apr; 35(5):1103-15. PubMed ID: 10758948
[TBL] [Abstract][Full Text] [Related]
8. Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes.
Kereiakes DJ; McDonald M; Broderick T; Roth EM; Whang DD; Martin LH; Howard WL; Schneider J; Shimshak T; Abbottsmith CW
Am Heart J; 2000 Feb; 139(2 Pt 2):S53-60. PubMed ID: 10650317
[No Abstract] [Full Text] [Related]
9. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Sabatine MS; Jang IK
Am J Med; 2000 Aug; 109(3):224-37. PubMed ID: 10974186
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.
Proimos G
J Thromb Thrombolysis; 2001 Apr; 11(2):99-110. PubMed ID: 11406724
[TBL] [Abstract][Full Text] [Related]
11. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
Ronner E; Dykun Y; van den Brand MJ; van der Wieken LR; Simoons ML
Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912
[No Abstract] [Full Text] [Related]
12. Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
Vernon SM
Cardiol Clin; 2001 May; 19(2):235-52, vi. PubMed ID: 11407108
[TBL] [Abstract][Full Text] [Related]
13. Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
MacCallum EM; Hanlon SJ; Byrne KH
Nursing; 1999 Dec; 29(12):34-9; quiz 40. PubMed ID: 10797693
[No Abstract] [Full Text] [Related]
14. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Adgey AA
Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
[TBL] [Abstract][Full Text] [Related]
15. Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment.
Tcheng JE
Am J Cardiol; 1999 May; 83(9A):7E-11E. PubMed ID: 10357575
[No Abstract] [Full Text] [Related]
16. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
Berkowitz SD
Haemostasis; 2000; 30 Suppl 3():27-43. PubMed ID: 11182626
[TBL] [Abstract][Full Text] [Related]
17. New antiplatelet agents for acute coronary syndromes.
Ferguson JJ; Lau TK
Am Heart J; 1998 May; 135(5 Pt 2 Su):S194-200. PubMed ID: 9588400
[No Abstract] [Full Text] [Related]
18. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
[TBL] [Abstract][Full Text] [Related]
19. Economic issues in glycoprotein IIb/IIIa receptor therapy.
Hillegass WB; Newman AR; Raco DL
Am Heart J; 1999 Jul; 138(1 Pt 2):S24-32. PubMed ID: 10385788
[TBL] [Abstract][Full Text] [Related]
20. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
Kereiakes DJ; Broderick TM; Roth EM; Whang D; Shimshak T; Runyon JP; Hattemer C; Schneider J; Lacock P; Mueller M; Abbottsmith CW
Am J Cardiol; 1999 Aug; 84(4):391-5. PubMed ID: 10468074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]